Skip to main content Skip to main navigation menu Skip to site footer
MedNext Journal of Medical and Health Sciences
Case Report
DOI: 10.54448/mdnt22S501
Submitted: 29-08-2022
Published: 29-08-2022

Oropharyngeal cancer: a clinical case report

UNORTE - University Center of Northern São Paulo - Dentistry department, Sao Jose do Rio Preto, Sao Paulo, Brazil
UNORTE - University Center of Northern São Paulo - Dentistry department, Sao Jose do Rio Preto, Sao Paulo, Brazil
UNIPOS - Post graduate and continuing education, Dentistry department, Sao Jose do Rio Preto, Sao Paulo, Brazil
Oropharyngeal Cancer Biopsy Diagnosis Prevalence HPV

Abstract

Introduction: The National Cancer Institute (INCA) estimates that for each year of the triennium 2020/2022, 15,190 new cases of cancer in the mouth and oropharynx are diagnosed in Brazil. In the global context, oropharyngeal cancer (OPC) is in the sixth position of cancer incidence. The most frequent form, about 90%, is squamous cell carcinomas. Objective: It was to present a clinical case report of oropharyngeal cancer in an octogenarian patient, to present the main diagnostic and treatment procedures in advanced age. Methods: The present study was elaborated according to the rules of the CARE case report. Scientific search engines: PubMed, Embase, Scopus, Google Scholar, Scientific Electronic Library Online (Scielo), published in Portuguese in the last 10 years. Case report and Conclusion: Based on the objective of this study and the literary findings, it showed that knowledge about OPC is essential for dental professionals, which plays a fundamental role in the diagnosis of oral cancers, requiring incisional biopsy. From the case described, it became evident the need for a partnership with a licensed psychologist, for the psychological preparation of the patient who will receive the news of the positive result for oropharyngeal cancer and the follow-up of the same throughout the treatment.

Metrics

Metrics Loading ...

References

  1. Buexm LA, Soares-Lima SC, Brennan P, Fernandes PV, de Souza Almeida Lopes M, Nascimento de Carvalho F, Santos IC, Dias LF, de Queiroz Chaves Lourenço S, Ribeiro Pinto LF. Hpv impact on oropharyngeal cancer patients treated at the largest cancer center from Brazil. Cancer Lett. 2020 May 1;477:70-75. doi: 10.1016/j.canlet.2020.02.023. Epub 2020 Feb 19. PMID: 32087309.
  2. Tanaka TI, Alawi F. Human Papillomavirus and Oropharyngeal Cancer. Dent Clin North Am. 2018 Jan;62(1):111-120. doi: 10.1016/j.cden.2017.08.008. Epub 2017 Oct 7. PMID: 29126488.
  3. Chimenos-Küstner E, Marques-Soares MS, Schemel-Suárez M. Consideraciones sobre etiopatogenia y prevención del cáncer orofaríngeo [Aetiopathology and prevention of oropharyngeal cancer]. Semergen. 2019 Oct;45(7):497-503. Spanish. doi: 10.1016/j.semerg.2019.03.004. Epub 2019 May 10. PMID: 31079896.
  4. Du J, Nordfors C, Ahrlund-Richter A, et al. Prevalence of oral human papillomavirus infection among youth, Sweden. Emerg Infect Dis. 2012;18:1468–71. doi: 10.3201/eid1809.111731.
  5. Habbous S, Chu KP, Lau H, et al. Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation. CMAJ. 2017;189:E1030–40. doi: 10.1503/cmaj.161379.
  6. Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34:299–309.
  7. Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB. The “new” head and neck cancer patient—young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg. 2014;151:375–80. doi: 10.1177/0194599814538605.
  8. Gallagher ST, Deal AM, Ballard D, Mayer DK. Oropharyngeal cancer and HPV: measuring knowledge and impact among survivors of head and neck cancer. Clin J Oncol Nurs. 2017;21:321–30. doi: 10.1188/17.CJON.321-330.
  9. Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014;50:380–6. doi: 10.1016/j.oraloncology.2013.12.019.
  10. Majchrzak E, Szybiak B, Wegner A, et al. Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiol Oncol. 2014;48:1–10. doi: 10.2478/raon-2013-0057.
  11. World Health Organization (WHO) Human papillomavirus (HPV) and cervical cancer [Web page] Geneva, Switzerland: who; 2018. [Available at: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer; cited 17 February 2019] [Google Scholar]
  12. Cates JR, Wong T, Semenciw R, Creel L. Human papillomavirus: a hidden epidemic in the United States [Web article] Washington, DC: Population Reference Bureau; 2001. [Available at: https://www.prb.org/humanpapillomavirusahiddenepidemicintheunitedstates; cited 17 February 2019]
  13. Aimagambetova G, Azizan A. Epidemiology of HPV infection and HPV-related cancers in Kazakhstan: a review. Asian Pac J Cancer Prev 2018; 19:1175–80.
  14. Bann D, Deschler D, Goyal N. Novel immunotherapeutic approaches for head and neck squamous cell carcinoma. Cancers (Basel) 2016;8:E87. doi: 10.3390/cancers8100087.
  15. Soria-Céspedes D, Canchola Aguilar G, Lara-Torres CO, Sánchez-Marle JF, Hernández-Peña RE, Ortiz-Hidalgo C. Carcinoma epidermoide orofaríngeo metastásico en ganglios linfáticos cervicales asociado a los subtipos 16 y 45 del virus del papiloma humano (VPH). Estudio clínico, morfológico y molecular de dos casos [Metastatic oropharyngeal squamous cell carcinoma in cervical lymph nodes associated to HPV infection type 16 and 45; clinical, morphological and molecular study of two cases]. Gac Med Mex. 2013 Nov-Dec;149(6):673-9. Spanish. PMID: 24276191].
  16. You EL, Henry M, Zeitouni AG. Human papillomavirus-associated oropharyngeal cancer: review of current evidence and management. Curr Oncol. 2019 Apr;26(2):119-123. doi: 10.3747/co.26.4819. Epub 2019 Apr 1. PMID: 31043814; PMCID: PMC6476447.
  17. Dixon L, Ramasamy S, Cardale K, et al. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma. Radiother Oncol. 2018;128:452–8. doi: 10.1016/j.radonc.2018.06.014.
  18. Dawe N, Patterson J, O’Hara J. Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management. Clin Otolaryngol. 2016;41:371–85. doi: 10.1111/coa.12526.
  19. Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol. 2015;272:463–71. doi: 10.1007/s00405-014-2985-7.
  20. Mehanna H, Robinson M, Hartley A, et al. on behalf of the DE-ESCALATE HPV trial group. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus–positive oropharyngeal cancer (DE-ESCALATE HPV): an open-label randomised controlled phase 3 trial. Lancet. 2019;393:51–60. doi: 10.1016/S0140-6736(18)32752-1.
  21. Høxbroe Michaelsen S, Grønhøj C, Høxbroe Michaelsen J, Friborg J, von Buchwald C. Quality of life in survivors of oropharyngeal cancer: a systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017;78:91–102. doi: 10.1016/j.ejca.2017.03.006.

How to Cite

Santana, G. C., Souza, G. A. de, & Leandro Moreira Tempest. (2022). Oropharyngeal cancer: a clinical case report. MedNEXT Journal of Medical and Health Sciences, 3(S5). https://doi.org/10.54448/mdnt22S501